Repaglinide D5 (AG-EE 623ZW D5) is deuterated form of Repaglinide. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus. References: [1]. Wang LC, et al. Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus.Medicine (Baltimore). 2018 Sep;97(38):e12476.

纯度：≥98%

CAS：1217709-85-7